Skip to content

Clinical trials

Hypertension, Pulmonary trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Country / region: Israel Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20051
20063
20071
20081
20094
20103
20112
20121
20133
20146
20152
20161
20172
20184
20192
20202
20213
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated12
Unknown status6
Active, not recruiting3
Enrolling by invitation2
Withdrawn1
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics9
Echosense Ltd.5
Merck Sharp & Dohme LLC4
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Actelion2
Bayer2
Biogen2
Carmel Medical Center2
Meir Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary48
Pulmonary Arterial Hypertension14
Hypertension6
Pulmonary Disease, Chronic Obstructive5
Heart Failure4
Lung Diseases4
Vascular Diseases4
Cardiovascular Diseases3
Familial Primary Pulmonary Hypertension3
Lung Diseases, Interstitial3

Trials

Showing 51 to 48 of 48. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.